International Journal of Drug Policy, Volume 72,Pages 1-198 (October 2019) Nearly 200 pages of open access articles from projects and research around the world. While this special issue highlights some successful efforts towards HCV elimination among people who inject drugs, it also highlights the relative lack of attention to settings in which resources enabling elimination are scarce, and where...
Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort. PLoS ONE. 2016;11(6):e0150655. doi:10.1371/journal.pone.0150655 Despite effective treatment for recent hepatitis C (HCV) infection, side-effects and adherence concerns limit its use among people who inject drugs (PWID). This study evaluated health-related quality of life...
Kirby Institute/UNSW – 21 February 2017
More Australians were treated for their hepatitis C infection in the first year new generation hepatitis C regimens were made available on the Pharmaceutical Benefits Schemes than in the past decade, according to a new report released today by the Kirby Institute at UNSW Sydney.
Read more here
Download report (PDF) here